Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD



Rating:

Share or cite this content

Citations should be made in the following way:
A. Papi (Ferrara, Italy), K. Chapman (Toronto, Canada), M. Castro (Kansas City, KS, United States of America), D. Jackson (Madison, WI, United States of America), N. Daizadeh (Cambridge, MA, United States of America), N. Pandit-Abid (Bridgewater, NJ, United States of America), Y. Deniz (Tarrytown, NY, United States of America), P. Rowe (Bridgewater, NJ, United States of America), B. Ortiz (Tarrytown, NY, United States of America). Impact of severe exacerbations on lung function in dupilumab-treated patients: LIBERTY ASTHMA QUEST. 2836

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of dupilumab in patients with oral corticosteroid (OCS)-dependent, severe asthma with and without an allergic phenotype: phase 3 LIBERTY ASTHMA VENTURE Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Dupilumab Efficacy in Asthma Patients With FEV1 60–80% Predicted on Medium-Dose ICS: LIBERTY ASTHMA QUEST Study Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Dysinapsis in COPD and ASTHMA Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003 Dupilumab shows rapid and sustained suppression of inflammatory biomarkers in asthma patients in LIBERTY ASTHMA QUEST Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE Source: Virtual Congress 2020 – ALERT: Asthma in adults and children Year: 2020 Dupilumab shows rapid and sustained suppression of inflammatory biomarkers in corticosteroid (CS)-dependent severe asthma patients in LIBERTY ASTHMA VENTURE Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 A MULTILATERAL APPROACH TO COPD COMORBIDITIES Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 LATE-BREAKING ABSTRACT: ASSOCIATION OF SEVERE EXACERBATION WITH FEV1 DECLINE AND LOSS OF AIRWAY REVERSIBILITY IN ASTHMA Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 DOES THE BENEFIT FROM PULMONARY REHABILITATION DIFFER BETWEEN PHENOTYPES IN COPD? Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 Factors associated with exacerbations in patients with COPD: NOVELTY study Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 EOSINOPHIL COUNT AND FeNO AS PREDICTORS OF EXACERBACTIONS IN COPD Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 BODE INDEX IN DIFFERENT PHENOTYPES OF COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Dupilumab improves asthma-related patient reported outcomes in asthma patients with chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 ARE THERE DIFFERENCES IN EXERCISE CAPACITY BY GENDER IN COPD PATIENTES? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 PEARL SCORE PREDICTION FOR MORTALITY IN SEVERE ACUTE COPD RE-EXACERBATION Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 COPD DIAGNOSIS: DIFFERENCES ACCORDING GENDER Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021 TREATMENT-RELATED DETERMINANTS OF THE RESPIRATORY MICROBIOME IN COPD Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Exacerbation burden in mild asthma: Evidence from the NOVELTY study Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 BENEFITS OF EARLY DIAGNOSIS AND TREATMENT OF OBSTRUCTIVE SLEEP APNEA-HYPOPNEA SYNDROME IN PATIENTS WITH ACUTE ISCHEMIC STROKE: SASS (Sleep Apnea in Stroke patients Study) Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019